SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-015219
Filing Date
2022-05-26
Accepted
2022-05-26 17:22:51
Documents
14
Period of Report
2022-05-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38526
2 ex10-1.htm EX-10.1 558179
3 ex10-1_001.jpg GRAPHIC 20168
  Complete submission text file 0001493152-22-015219.txt   899121

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT invo-20220523.xsd EX-101.SCH 3051
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT invo-20220523_lab.xml EX-101.LAB 34476
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT invo-20220523_pre.xml EX-101.PRE 22607
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3499
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39701 | Film No.: 22971487
SIC: 3841 Surgical & Medical Instruments & Apparatus